Your browser doesn't support javascript.
loading
Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia.
Kubasch, Anne Sophie; Wehner, Rebekka; Bazzurri, Serena; Tunger, Antje; Stasik, Sebastian; Garzarolli, Marlene; Meinel, Jörn; Baretton, Gustavo; Meier, Friedegund; Thiede, Christian; Schmitz, Marc; Platzbecker, Uwe.
Afiliação
  • Kubasch AS; Center for Rare Diseases, University Hospital Carl Gustav Carus.
  • Wehner R; Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus.
  • Bazzurri S; Institute of Immunology, Medical Faculty Carl Gustav Carus, and.
  • Tunger A; National Center for Tumor Diseases, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Stasik S; German Cancer Consortium, Dresden, Germany.
  • Garzarolli M; German Cancer Research Center, Heidelberg, Germany.
  • Meinel J; Department of Oncology, Santo Stefano Hospital, Prato, Italy; and.
  • Baretton G; Institute of Immunology, Medical Faculty Carl Gustav Carus, and.
  • Meier F; National Center for Tumor Diseases, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Thiede C; Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus.
  • Schmitz M; Department of Dermatology and.
  • Platzbecker U; Institute of Pathology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Blood Adv ; 2(11): 1187-1190, 2018 06 12.
Article em En | MEDLINE | ID: mdl-29844203

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Segunda Neoplasia Primária / Anticorpos Monoclonais Humanizados / Melanoma / Mutação / Proteínas de Neoplasias Limite: Aged80 / Humans / Male Idioma: En Revista: Blood Adv Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Segunda Neoplasia Primária / Anticorpos Monoclonais Humanizados / Melanoma / Mutação / Proteínas de Neoplasias Limite: Aged80 / Humans / Male Idioma: En Revista: Blood Adv Ano de publicação: 2018 Tipo de documento: Article